Osimertinib in EGFR T790M-Positive NSCLC Patients With Brain Metastases or Leptomeningeal Disease Who Progressed on Prior EGFR TKI Therapy
Written by Sarah B. Goldberg MD, MPH
Written by Sarah B. Goldberg MD, MPH
Read it now on PracticeUpdate.com
Read it now on PracticeUpdate.com
Interview with Lee S. Schwartzberg MD, FACP
Read it now on PracticeUpdate.com
Interview with David Henry MD
Interview with David Henry MD